Enhancement of the immune response
作者： Richard S. Blumberg , Yu-Hwa Huang
DOI:
关键词:
摘要: The technology described herein relates to compositions and methods for enhancing the immune response and/or reducing T cell tolerance in a subject. In some embodiments, administering inhibitors of two or more CEACAM1, PD1, LAP to, e.g., synergistically reduce tolerance.
wipo.int
lens.org参考文章(131)
Zena Werb, Lisa M. Coussens, Novel indications for transforming growth factor-beta regulators ,(2004)
Gonda I, Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract. Critical Reviews in Therapeutic Drug Carrier Systems. ,vol. 6, pp. 273- 313 ,(1990)
Danny H. Lewis, Controlled Release of Pesticides and Pharmaceuticals ,(2013)
David A. Hafler, Vijay K. Kuchroo, Ana C. Anderson, David E. Anderson, Therapeutic uses of tim-3 modulators ,(2007)
Daniel M. Linkie, Michael O. Thorner, Apparatus and methodology for pulsed administration of growth promoting agents. ,(1985)
Elvin A. Kabat, Sequences of proteins of immunological interest National Institutes of Health. ,(1991)
Ana M. Texieira, Atul K. Bhan, Atsushi Mizoguchi, Richard S. Blumberg, Emiko Mizoguchi, Gordon J. Freeman, Gary J. Russell, Victor M. Morales, Nalan Utku, Sara E. Russell, Kevin W. Johnson, Andreas Christ, Suzanne M. Watt, Hyun S. Kim, Regulation of human intestinal intraepithelial lymphocyte cytolytic function by biliary glycoprotein (CD66a) Journal of Immunology. ,vol. 163, pp. 1363- 1370 ,(1999)
Soichi Kojima, Wakako Kondo, Naoshi Dohmae, Antibodies That Recognize Cutting Edge Within The Tgf-Beta Activation Controlling Region ,(2010)
Atul Bhan, Richard S Blumberg, Therapeutic anti-BGP(C-CAM1) antibodies and uses thereof ,(2002)